Ewing's sarcoma family tumours: Differences in clinicopathological characteristics at presentation between localised and metastatic tumours

Journal of Bone and Joint Surgery - Series B

Volumn 89, Issue 9, 2007, Pages 1229-1233

  Bacci, G ^a   Balladelli, A ^a   Forni, C ^a   Longhi, A ^a   Serra, M ^a   Fabbri, N ^a   Alberghini, M ^a   Ferrari, S ^a   Benassi, M S ^a   Picci, P ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LACTATE DEHYDROGENASE;

ADOLESCENT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EWING SARCOMA; FEMALE; FEVER; HUMAN; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PATHOLOGY; PELVIS TUMOR; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SYMPTOMATOLOGY; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; BONE NEOPLASMS; CHILD; FEMALE; FEVER; HUMANS; L-LACTATE DEHYDROGENASE; MALE; MULTIVARIATE ANALYSIS; RISK FACTORS; SARCOMA, EWING'S;

EID: 35848957952     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.89B9.19422     Document Type: Article

References (27)

1. Burgert EO. Nesbit ME, Garnsey LA, et al. Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone' intergroup study IESS-II. J Clin Oncol 1990;8:1514-24.
2. Nesbit ME, Gehan EA, Burgert EO, et al. Multimodal therapy for the management of primary nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study. J Clin Oncol 1990;8:1664-74.
3. Oberlin O, Deley MC, Bui BN, et al. Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study). Br J Cancer 2001;85:1646-54.
4. Craft AW, Cotterill SJ, Bullimore JA, Pearson D. Long-term results from the first UKCCSG Ewing's Tumour Study (ET-1): United Kingdom children's cancer study group (UKCCSG) and the medical research council bone sarcoma working party. Eur J Cancer 1997;33:1061-9.
5. Paulussen M, Ahrens S, Dunst J, et al. Localized Ewing tumor of bone: final results of the cooperative Ewing's sarcoma study CESS 86. J Clin Oncol 2001;19:1818-29.
6. Grier HE, Krailo M, Tarbell NJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003;348:694-701.
7. Oberlin O, Rey A, Descachelles AS, et al. Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Societe Francaise des Cancers de l'Enfant. J Clin Oncol 2006;24:3997-4002.
8. Marina NM, Pappo AS, Parham DM, et al. Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round-cell tumors: a feasibility study at St Jude Children's Research Hospital. J Clin Oncol 1999;17:180-90.
9. Cangir A, Vietti TJ, Gehan EA, et al. Ewing's sarcoma metastatic at diagnosis: results and comparisons of two intergroup Ewing's sarcoma studies. Cancer 1990;66:887-93.
10. Meyers PA, Krailo MD, Ladanyi M, et al. High-dose melphalan, etoposide, total-body irradiation, and autologus stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis. J Clin Oncol 2001;19:2812-20.
11. Bacci G, Di Fiore M, Rimondini S, Baldini N. Delayed diagnosis and tumor stage in Ewing's sarcoma. Oncol Rep 1999;6:465-6.
12. Gobel V, Jurgens H, Etspuler G, et al. Prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescents. J Cancer Res Clin Oncol 1987;113:187-91.
13. Boyer CW, Brickner TJ, Perry RH. Ewing's sarcoma: case against surgery. Cancer 1967;20:1602-6.
14. Falk S, Alpert M. Five-year survival of patients with Ewing's sarcoma. Surg Gynecol Obstet 1967;124:319-24.
15. Jurgens H, Exner U, Gadner H, et al. Multidisciplinary treatment of primary Ewing's sarcoma of bone: a 6-year experience of a European Cooperative trial. Cancer 1988;61:23-32.
16. Cotterill SJ, Ahrens S, Paulussen M, et al. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol 2000;18:3108-14.
17. Smeland S, Wiebe T, Brosio O, Bohling T, Alvegard TA. Chemotherapy in Ewing's sarcoma: the Scandinavian Sarcoma Group experience. Acta Orthop Scand (Suppl) 2004;75:87-91.
18. Farley FA, Healey JH, Caparros-Sison B, et al. Lactate dehydrogenase as a tumor marker for recurrent disease in Ewing's sarcoma. Cancer 1987;59:1245-8.
19. Bacci G, Ferrari S, Bertoni F, et al. Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Instituto Ortopedico Rizzoli. J Clin Oncol 2000;18:4-11.
20. Delepine N, Delepine G, Cornille H, et al. Prognostic factors in patients with localized Ewing's sarcoma: the effect on survival of actual received drug dose intensity and of histologic response to induction therapy. J Chemotherapy 1997;9:352-63.
21. Bosl GJ, Vogelzang NJ, Goldman A, et al. Impact of delay in diagnosis on clinical stage of testicular cancer. Lancet 1981;31:970-3.
22. Christensen ED, Harvald T, Jendresen M, Aggestrup S, Petterson G. The impact of delayed diagnosis of lung cancer on the stage at the time of operation. Eur J Cardiothorac 1997;12:880-4.
23. Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence on delay on survival in patients with breast cancer: a systematic review. Lancet 1999;353:1119-26.
24. Roncoroni L, Pietra N, Violi V, et al. Delay in the diagnosis and outcome of colorectal cancer: a prospective study. Eur J Surg Oncol 1999;25:173-8.
25. Miziara D, Cahali MB, Murakami M, Figueiredo LA, Guimaraes JR. Cancer of larynx: correlation of clinical characteristics, site of origin, stage, histology and diagnostic delay. Rev Laryngol Otol Rhinol 1998;119:101-4.
26. Pirog EC, Heller DS, Westhoff C. Endometral adeenocarcinoma lack of correlation treatment delay and tumor stage. Gynecol Oncol 1997;67:303-8.
27. Bacci G, Ferrari Sm Longhi A, et al. Delay in diagnosis of high grade osteosarcoma of the extremities: has it any effect on the stage of the disease? Tumori 2000;86:204-6.